Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 09-2010 | 12-2009 | 12-2008 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | N/A | 15,210 | 6,270 |
| Marketable Securities | N/A | N/A | 1,990 | 1,850 |
| Receivables | N/A | N/A | 1,340 | 0 |
| Other current assets | 0 | 0 | 350 | 650 |
| TOTAL | $N/A | $N/A | $18,890 | $8,770 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | 4,480 | 2,220 |
| Other Non-Current Assets | 0 | 0 | 850 | 0 |
| TOTAL | $N/A | $N/A | $5,330 | $2,220 |
| Total Assets | $N/A | $N/A | $22,660 | $10,570 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 1,080 | 600 |
| Accrued Expenses | N/A | N/A | 1,170 | 1,230 |
| Other current liabilities | N/A | N/A | 950 | 6 |
| TOTAL | $N/A | $N/A | $3,240 | $1,840 |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | N/A | 6,000 | 6,000 |
| Other Non-Current Liabilities | 0 | 35 | 54,130 | 34,550 |
| TOTAL | $N/A | $N/A | $60,200 | $40,554 |
| Total Liabilities | $N/A | $N/A | $63,450 | $42,400 |
| Shareholders' Equity | ||||
| Common Shares | N/A | N/A | 60 | 60 |
| Retained earnings | N/A | N/A | -47,170 | -37,520 |
| Other shareholders' equity | 0 | 0 | 3,570 | 3,540 |
| TOTAL | $N/A | $N/A | $-40,780 | $-31,830 |
| Total Liabilities And Equity | $0 | $0 | $22,670 | $10,570 |